83 related articles for article (PubMed ID: 10905554)
1. A cationic derivative of amphotericin B as a novel delivery system for antisense oligonucleotides.
Garcia-Chaumont C; Seksek O; Jolles B; Bolard J
Antisense Nucleic Acid Drug Dev; 2000 Jun; 10(3):177-84. PubMed ID: 10905554
[TBL] [Abstract][Full Text] [Related]
2. Novel chemically modified oligonucleotides provide potent inhibition of P-glycoprotein expression.
Alahari SK; DeLong R; Fisher MH; Dean NM; Viliet P; Juliano RL
J Pharmacol Exp Ther; 1998 Jul; 286(1):419-28. PubMed ID: 9655887
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of expression of the multidrug resistance-associated P-glycoprotein of by phosphorothioate and 5' cholesterol-conjugated phosphorothioate antisense oligonucleotides.
Alahari SK; Dean NM; Fisher MH; Delong R; Manoharan M; Tivel KL; Juliano RL
Mol Pharmacol; 1996 Oct; 50(4):808-19. PubMed ID: 8863825
[TBL] [Abstract][Full Text] [Related]
4. Changes of conductance and compressibility of bilayer lipid membranes induced by oligonucleotide-cationic polyene antibiotic complexes.
Hianik T; Ostatnik L; Polohova V; Bolard J
Bioelectrochemistry; 2008 Nov; 74(1):2-8. PubMed ID: 17904427
[TBL] [Abstract][Full Text] [Related]
5. Oligonucleotide delivery by a cationic derivative of the polyene antibiotic amphotericin B. I: interaction oligonucleotide/vector as studied by optical spectroscopy and electron microscopy.
Blanc I; Bueno Da Costa M; Bolard J; Saint-Pierre Chazalet M
Biochim Biophys Acta; 2000 Apr; 1464(2):299-308. PubMed ID: 10727616
[TBL] [Abstract][Full Text] [Related]
6. In vitro and in vivo reversal of multidrug resistance in a human leukemia-resistant cell line by mdr1 antisense oligodeoxynucleotides.
Cucco C; Calabretta B
Cancer Res; 1996 Oct; 56(19):4332-7. PubMed ID: 8813118
[TBL] [Abstract][Full Text] [Related]
7. Oligonucleotide delivery by a cationic derivative of the polyene antibiotic amphotericin B. II: study of the interactions of the oligonucleotide/cationic vector complexes with lipid monolayers and lipid unilamellar vesicles.
Blanc I; Saint-Pierre Chazalet M
Biochim Biophys Acta; 2000 Apr; 1464(2):309-21. PubMed ID: 10727617
[TBL] [Abstract][Full Text] [Related]
8. Selecting optimal oligonucleotide composition for maximal antisense effect following streptolysin O-mediated delivery into human leukaemia cells.
Giles RV; Spiller DG; Grzybowski J; Clark RE; Nicklin P; Tidd DM
Nucleic Acids Res; 1998 Apr; 26(7):1567-75. PubMed ID: 9512525
[TBL] [Abstract][Full Text] [Related]
9. Minimally modified phosphodiester antisense oligodeoxyribonucleotide directed against the multidrug resistance gene mdr1.
Brigui I; Djavanbakht-Samani T; Jollès B; Pigaglio S; Laigle A
Biochem Pharmacol; 2003 Mar; 65(5):747-54. PubMed ID: 12628488
[TBL] [Abstract][Full Text] [Related]
10. Biological effects and cellular uptake of c-myc antisense oligonucleotides and their cationic liposome complexes.
Kanamaru T; Takagi T; Takakura Y; Hashida M
J Drug Target; 1998; 5(4):235-46. PubMed ID: 9713974
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of MDR1 gene expression by chimeric HNA antisense oligonucleotides.
Kang H; Fisher MH; Xu D; Miyamoto YJ; Marchand A; Van Aerschot A; Herdewijn P; Juliano RL
Nucleic Acids Res; 2004; 32(14):4411-9. PubMed ID: 15316104
[TBL] [Abstract][Full Text] [Related]
12. Increased uptake of antisense oligonucleotides by delivery as double stranded complexes.
Astriab-Fisher A; Fisher MH; Juliano R; Herdewijn P
Biochem Pharmacol; 2004 Aug; 68(3):403-7. PubMed ID: 15242806
[TBL] [Abstract][Full Text] [Related]
13. Effect of MDR1 phosphorothioate antisense oligodeoxynucleotides in multidrug-resistant human tumor cell lines and xenografts.
Ramachandran C; Wellham LL
Anticancer Res; 2003; 23(3B):2681-90. PubMed ID: 12894558
[TBL] [Abstract][Full Text] [Related]
14. A serum-resistant cytofectin for cellular delivery of antisense oligodeoxynucleotides and plasmid DNA.
Lewis JG; Lin KY; Kothavale A; Flanagan WM; Matteucci MD; DePrince RB; Mook RA; Hendren RW; Wagner RW
Proc Natl Acad Sci U S A; 1996 Apr; 93(8):3176-81. PubMed ID: 8622909
[TBL] [Abstract][Full Text] [Related]
15. Oligonucleotides tethered to a short polyguanylic acid stretch are targeted to macrophages: enhanced antiviral activity of a vesicular stomatitis virus-specific antisense oligonucleotide.
Prasad V; Hashim S; Mukhopadhyay A; Basu SK; Roy RP
Antimicrob Agents Chemother; 1999 Nov; 43(11):2689-96. PubMed ID: 10543748
[TBL] [Abstract][Full Text] [Related]
16. Polyethylenimine but not cationic lipid improves antisense activity of 3'-capped phosphodiester oligonucleotides.
Dheur S; Dias N; van Aerschot A; Herdewijn P; Bettinger T; Rémy JS; Hélène C; Saison-Behmoaras ET
Antisense Nucleic Acid Drug Dev; 1999 Dec; 9(6):515-25. PubMed ID: 10645777
[TBL] [Abstract][Full Text] [Related]
17. The role of MDR1 gene in volume-activated chloride currents in pigmented ciliary epithelial cells.
Chen LX; Wang LW; Jacob T
Sheng Li Xue Bao; 2002 Feb; 54(1):1-6. PubMed ID: 11930232
[TBL] [Abstract][Full Text] [Related]
18. A novel, long-circulating, and functional liposomal formulation of antisense oligodeoxynucleotides targeted against MDR1.
Stuart DD; Kao GY; Allen TM
Cancer Gene Ther; 2000 Mar; 7(3):466-75. PubMed ID: 10766353
[TBL] [Abstract][Full Text] [Related]
19. Intracellular uptake of modified oligonucleotide studied by two fluorescence techniques.
Kocisová E; Praus P; Rosenberg I; Seksek O; Sureau F; Stĕpánek J; Turpin PY
Biopolymers; 2004 May-Jun 5; 74(1-2):110-4. PubMed ID: 15137106
[TBL] [Abstract][Full Text] [Related]
20. Antisense oligonucleotide delivery with polyhexylcyanoacrylate nanoparticles as carriers.
Zimmer A
Methods; 1999 Jul; 18(3):286-95, 322. PubMed ID: 10454987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
